Gosforth Centre (holdings) Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2007-03-20 and was issued with the 124514950 ACN. Its Australian Business Number is 86124514950. Since 2007-03-20, the company is headquartered in QLD, post code 4558. Gosforth Centre (holdings) Pty Ltd was registered for the GST on 2012-07-01. The above data comes from the ABN database which was updated on 2012-09-19.
| Status | From | To |
|---|---|---|
| Active | 2007-03-20 | current |
| Name | From | To |
|---|---|---|
| Gosforth Centre (holdings) Pty. Ltd. | 2007-03-20 | current |
| Location | From | To |
|---|---|---|
| QLD 4558 | 2007-03-20 | current |
| Status | From | To |
|---|---|---|
| Registered | 2012-07-01 | current |
Advertisements
General information:
| Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61P 25/18 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | P - specific therapeutic activity of chemical compounds or medicinal preparations |
| Main group code: | 25 - drugs for disorders of the nervous system |
| Subgroup code: | 18 - antipsychotics, i.e. neuroleptics; drugs for mania or schizophrenia |
IP Australia process information:
| Expiry date: | 2028-02-07 |
General information:
| Patent status: |
Lapsed Either the application has not been accepted by 21 months after the first examination report (or 12 months after the Raising the Bar Act) or some other deadline in the prosecution process has not been completed in time, for example IP Australia has issued a direction to file a request for examination and the applicant has not done so in the required period (2 months). |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61P 25/26 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | P - specific therapeutic activity of chemical compounds or medicinal preparations |
| Main group code: | 25 - drugs for disorders of the nervous system |
| Subgroup code: | 26 - psychostimulants, e.g. nicotine, cocaine |
IP Australia process information:
| Expiry date: | 2027-03-30 |
General information:
| Patent status: |
Filed The specification prior to acceptance and where the application has not lapsed |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61P 25/18 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | P - specific therapeutic activity of chemical compounds or medicinal preparations |
| Main group code: | 25 - drugs for disorders of the nervous system |
| Subgroup code: | 18 - antipsychotics, i.e. neuroleptics; drugs for mania or schizophrenia |
IP Australia process information:
| Expiry date: | 2029-08-06 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.